ROUND TABLE ARISLA Milano 26 marzo 2014 Le BioBanche Nodo Italiano di Biobanking and Biomolecular Resources Research Infrastructure

Similar documents
A Gateway for Health: BBMRI and Africa Prof. Jan-Eric Litton Director General BBMRI-ERIC

Biobanking and Biomolecular Resources Research Infrastructure: The need for common standards

Arto Mannermaa. Research Manager, KUH Professor of personalized medicine and Biobanking, UEF

1.0 Background to the organisation

This document is a preview generated by EVS

Examples of best practices for capacity building in Africa. Dr Maimuna Mendy, Head LSB Group (LSB/DIR) ibb.iarc.fr bcnet.iarc.

The Hellenic Network of Biobanks-BBMRI-GR Dr. S.Kolyva Representative of Greece in the General Assembly of BBMRI-ERIC

HOW CAN BIOBANKING DELIVER ON THE PROMISES OF PERSONALISED MEDICINE? FRANCESCO FLORINDI STRATEGY & PARTNERSHIP MANAGER

How European RIs can boost Open Science & Open Innovation

This document is a preview generated by EVS

Expert Centres for Improved Access to Research Infrastructures

IBBL: Introduction to Biobanks and their services

This document is a preview generated by EVS

This document is a preview generated by EVS

- OMICS IN PERSONALISED MEDICINE

Cancer survival trends and inequalities: what is the role for Europe?

Biobanks for biomedical research

The European Commission s strategy on Corporate Social Responsibility (CSR) : achievements, shortcomings and future challenges

European Induced Pluripotent Stem Cell Bank

Eurostat current work on resource-efficient circular economy Renato Marra Campanale

BBMRI.at. Biobanking and BioMolecular resources Research Infrastructure Austria

to ensure that the public is properly informed about the state of the environment.

SUCCESSFUL BRANDS: LATVIA ESTONIA CROATIA GERMANY UNITED KINGDOM BOSNIA-HERZEGOVINA BULGARIA MACEDONIA SERBIA CZECH REPUBLIC SLOVAKIA FRANCE AUSTRIA

Synthetic Biology and Patents

The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence

Integrated Programme of Work for the ECE Committee on Forests and the Forest Industry and the FAO European Forestry Commission

Vocational Education and Training (VET) Systems: Role of the Social Partners

Organic markets for fruit and vegetables in Europe

Public consultation on enhanced cooperation between Public Employment Services (PES)

Making More Efficient Use of Biospecimens. ISBER Contributions and Initiatives

Overview: National coal phase-out announcements in Europe

GMP. Safeguard The Patient s Health.

PERSONALIZED CANCER CARE

ESF Ex-Post evaluation

BBMRI.at. Biobanking and BioMolecular resources Research Infrastructure Austria

European Union (EU) Falsified Medicines Directive

ENVIRONMENTAL RISK ASSESSMENTS: EU CLINICAL TRIALS WITH GMO-BASED ATMPS ANN GORMAN, AMGEN LTD, UK 16 DECEMBER 2016

Comments about Rare diseases: Europe s challenge from the Public and Professional Policy Committee of the European Society for Human Genetics.

The European Commission s strategy on Corporate Social Responsibility (CSR) : achievements, shortcomings and future challenges

Economic and Social Council

Personalized. Health in Canada

OPEN SCIENCE From Vision to Action

Patient organisation direct access to Biobanks

Presentation 2. The Common Assessment Framework CAF 2013

Biobanks in Spain. An overview.

ONLINE submission form of the Research Infrastructure proposal to the 2016 ESFRI Roadmap

COMMISSION OF THE EUROPEAN COMMUNITIES

BIG DATA: from the Moli-sani project to the Neuromed integrated health platform and Biobank

Planning, implementation, follow-up and review of the Sustainable Development Goals

RESOLUTION RES (2002) 3 ADOPTING THE REVISED STATUTE OF THE EUROPEAN COMMISSION FOR DEMOCRACY THROUGH LAW

OECD RECOMMENDATION OF THE COUNCIL FOR ENHANCED ACCESS AND MORE EFFECTIVE USE OF PUBLIC SECTOR INFORMATION [C(2008)36]

Vision, aims and strategies. Department of Immunology, Genetics and Pathology Uppsala University

Governance versus e-governance: e Procurement

CAP CONTEXT INDICATORS

Danish and European plans for wind energy deployment

Council of the European Union Brussels, 8 December 2017 (OR. en)

Environmental Attitudes

OECI WORKING GROUP HIGHLIGHTS

BBMRI.NL A story of Sharing Eline Slagboom Molecular Epidemiology, Leiden University Medical Center Brussel 20 Juni 2017

Joint Programming in Neurodegenerative Disease Research (JPND)

OECD LEED TRENTO CENTRE FOR LOCAL DEVELOPMENT INFORMATION BROCHURE

UE Biopathologie et Biobanking

How2Guide for Bioenergy. Ingrid Barnsley, Anselm Eisentraut Southeast Asia regional workshop July 2014, Bangkok, Thailand

Planning, implementation, follow-up and review of the Sustainable Development Goals

Session 13: Prequalification Within the Context of Global Fund Procurements

The Common Assessment Framework CAF Principles, background, headlines

GLOBAL COALITION FOR GOOD WATER GOVERNANCE

Cutting Red Tape The Member State point of view. Presentation by Hilde Van de Velde Bruges March 2010

Quality Management System and Standardization for. Biobanks and bioresources ISO/TC 276

Rethinking E-Government Services

Precision Medicine. Presented by:

Public opinion on new technologies in the European Union

Asterand Bioscience Strategic Alliances

TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS

A framework for quality management in the biomedical research infrastructures (BMS RIs)

This document is a preview generated by EVS

The European Medical Technology Industry. in figures / 2018

Standards, Harmonisation and Audit. Anne Carter

Environmental Best Practices, It Begins with Us: Business, Local Governments and International Community Should Work Together

BIOPHARMACEUTICALS Availability, Diffusion, Sustainability. Massimo Riccaboni University of Florence & CERM, Rome

Le banche dei tessuti

BCNetter. Issue No. 5, September Message from the Editor. In this issue

This document is a preview generated by EVS

Dedicated to Molecular Diagnostics

Antilope refinement of the eeif

4th Quality Conference (4QC) Impact Assessment Study. Agenda

Emissions Trading System (ETS): The UK needs to deliver its share of the total EU ETS emissions reduction of 21% by 2020, compared to 2005;

Public Consultation on the European Solidarity Corps

UTILITIES: HOW THE EU DIRECTIVE IS IMPLEMENTED AND HOW IT WORKS IN EU MEMBER STATES

Public Consultation on the European Solidarity Corps

The Ethics dimension of PA Civil Servants

GRECO IN THE MIDST OF ITS FOURTH EVALUATION ROUND. Christian Manquet, Vice-President of GRECO

Using Human Tissue in Translational Research and Clinical Trials

Annual Dinner Debate 2015

TRANSLATIONAL RESEARCH IN RARE AND NEUROMUSCULAR DISEASES - WHY DATA SHARING MATTERS. H a n n s Lochmüller, Newcastle University

Future forest research in Europe

Organic market & trade: what current figures don't say Raffaele Zanoli

CFI SUBMISSION FORM I. CS4 AFUAS: Advanced Flexible Use of Airspace Support Service (AFUAS)

CONCEPT PAPER. ASIA-EUROPE ENVIRONMENT FORUM 4 TH ROUNDTABLE Combine or Combust! Co-operating on Chemicals and Hazardous Substances Management

High-Level Public Administration Conference For a Business-Friendly Public Administration Brussels, 29 October 2013

Transcription:

ROUND TABLE ARISLA Milano 26 marzo 2014 Le BioBanche Nodo Italiano di Biobanking and Biomolecular Resources Research Infrastructure Marialuisa Lavitrano Università Milano-Bicocca Coordinatore BBMRI-Italia

Time, March 13 th, 2009 Biobanks

Biological resources living organisms, cells, genes, and related information are the essential raw material for the advancement of biotechnology, human health, and research and development in life sciences OECD 2001

The European Strategy Forum for Research Infrastructures Roadmap One infrastructure for biobanks and biomolecular resources Scientific excellence Pan-European Access to resources and services Long-term sustainability (international integration)

BBMRI-ERIC Mission Increase efficacy and excellence of European bio-medical research: by facilitating access to quality-defined human health/diseaserelevant biological resources including associated data in an efficient and ethically and legally compliant manner, by reducing the fragmentation of the bio-medical research landscape through harmonization of procedures, implementation of common standards and fostering high-level collaboration, by capacity building in countries with less developed biobanking communities thereby contributing to Europe s cohesion policy and strengthening the ERA.

Scientific Excellence Quality of samples and data Coverage of European populations/patients Interoperability Ethical and legal compliance

BBMRI-ERIC: A pan-european Infrastructure 14 Founding Members: Austria, Bulgaria, Belgium, Czech Rep., Estonia, Finland, France, Germany, Greece, Italy, Latvia, Malta, Netherlands, Sweden 4 Observers: Norway, Poland, Switzerland and Turkey

BBMRI-ERIC: A Distributed Research Infrastructure Distributed hub and spoke structure Statutory seat (CEMO Austria, Graz) National nodes Associated partners Hospitals Universities Service providers

The ERIC Legal Framework Internationally recognized legal entity Establishement of operational sites in different Member States that operate under one legislation VAT exemption

The Italian Infrastructure for Biobanks

THE ITALIAN BIOBANK NETWORK IRCCS Ministry of Health Natl Institute of Health Hospitals Ministry of University and Research Universities Natl Research Council Patient associations GENETIC BBs ARCHIVE TISSUES BBs ONCOLOGY BBs ITALIAN NETWORK DISEASE-ORIENTED BBs MULTI SPECIALIST BBs VASCULAR BBs ISOLATES POPULATION BBs RANDOM COHORTS

BBMRI-IT Facts and figures BBMRI-IT is a distributed infrastructure including BBs & Biological Resources Centres allocated all over Italy They include, among others: 18 Universities 23 IRCCS (Institute of health care and research) 40 Hospitals 8 patient associations about 90 BBs, Biological Resources Centres and Collections 290 individuals (research groups) have formally declared their willingness to join BBMRI-IT

THE ITALIAN BIOBANK NETWORK Population biobanks, genetic or diseaseoriented biobanks are characterized by a collection of biological samples, such as blood, tissues and/or DNA, plus associated epidemiological, clinical, and research data, which may be important research tools for identification of new targets for therapy and may help in drug discovery and development. 1.000.000 cases collected 80.000 new cases / year

THE ITALIAN BIOBANK NETWORK Biobank Specimen Archives have large collections of well-documented, up-to-date clinical and biological information samples, supplied with links to epidemiological and health care information and in most cases with the molecular genomic resources, which can support retrospective studies and accelerate research progress. 240.000.000 cases collected 12.000.000 new cases / year All specimens are stored for at least 20 years

BBMRI-IT Aims BBMRI-IT main goals: to take Italian collections of biological resources, BBs and networks to a new level of coordination and efficiency to supply new common services for the community of the Italian biobanks to provide better access for users from public and private sector to contribute to the pan-european research infrastructure BBMRI-ERIC

BBMRI-IT Aims To achieve the aims Improve interoperability of research databases Provide tools to facilitate public/private partnership Develop conditions to ensure sustainability of BBs Harmonize SOPs and elaborate appropriate tools Implement quality management criteria Interface with BBMRI-ERIC by developing a national node

PATH OF BBMRI IT MEMBERSHIP First step: a survey has been designed to map and select well established Italian biobanks in terms of the level quality and richness in samples and data. Second step: an on-line self evaluation form have been administered, followed by the creation, in the new web site of the node, of a web page for each biobank / biological resource centre of the network. Third step: provide support, advice and documents to those willing to set new biobanks and / or improve the quality of their collections of biological samples.

16% were already operative before 1990, while 56% were set up after 2001 43% have more than 10.000 cases collected 66% collect at least 3 different types of samples per subject (frozen samples, FFPE, blood derivatives, nucleic acids, cell lines) 77% belong to regional, Natl and/or Intl networks Most are disease oriented, and about half are specialized in cancer and genetic diseases A vaste majority is ready to offer services oncology to the network (samples, 30% data, molecular analysis, expertise, support in handling, preservation, transfer) Results of the survey Neuro degenerative disorders 6% Focus of the biobanks Oncology 30% Products and services offered to the network Population studies 14% Sample handling, preservation and transfer 26%

Thematic and Multispecialty BB Networks BBMRI IT MATRIX ARCHITECTURE Italian Regional Biobank Networks Region 1 Region 2 Region 3 Region 4 Region 5 Region 6 Region n Multispecialty bb Oncology bb Archive Tissues Genetic bb Vascular bb Population and Isolates bb

NHS - Regional initiatives on biobanks Italy s health care system is a regionally organized Regional Authorities with regards to biobanks are responsible of: authorization funding monitoring & control Since 2011, National and Regional Institutions have set up a Task Force on biobank management and monitoring Some Regions have already put in place specific resolutions and laws

STRUCTURE OF THE ITALIAN NODE Ministry of Health Ministry of University and Research Regions National Institute of Health (ISS) National Research Council (CNR) Coordinator Member State Representative Governing Board Evaluation Board Network Board Secretariat (E Bravo) Scientific Board Stakeholder forum Service 1 Quality Management (B Parodi) Service 2 Harmonization (M Filocamo) Service 3 SOPs, Validation, training (MG Daidone) Service 4 Technology and Reagent (G Stanta) Service 5 Information Communication Technology (L Milanesi) Service 6 Ethical, Legal and Societal issues (M Lavitrano) Model for Regional biobank networks ( L Santi)

Common Service IT Services Sustain the matrix architecture of the network (links among BBs into Regional and thematic networks) Offer common services to the network Promote collaborative studies at the National and International levels Guarantee safe transfer of information Provide visibility to Italian BBs Adopt BBMRI standards and create the interface to National BBs Maintain the Lexicon BBMRI portal for multi-lingual BBs terminology definition Luciano Milanesi

Common Service Common Technology and Reagent Services Establish a National catalogue of facilities and services for the biobank network Identify Expert Centres Catalogue of services offered by BBs to the network DNA and RNA extraction supply of genetic material for method validation cell line production molecular characterization of biological samples cell line authentication validated mycoplasma QC cryopreservation biological samples preparation and storage pathogens Giorgio Stanta consultancy biological samples transport (IATA) statistical analysis counseling SOPs preparation counseling ethical issues data analysis data mining training of operators for cryobiology training of operators for biobanking

Sample Quality: Critical Issues Medication Surgical procedure Warm ischemia Fixation Fixative Time Transport Temperature Cold ischemia Sample processing Mech. alteration Selection+annotation Aliquotting Embedding Temperature Diagnosis Disease codes Storage Time temperature Freezing Freezing rate Temperature Cryostorage Temperature Temp. shifts Sample preparation Analysis

Common Service Quality Services Map and monitor BBs, repositories and biomolecular resources Harmonize and standardize SOPs Develop criteria for accreditation & certification Implement quality management criteria Improve interoperability Set up training in quality control Standardize and set up proficiency testing Promote a certification program Mirella Filocamo, Mariagrazia Daidone, Barbara Parodi

Common Service Ethical, Legal and Societal Issues Define the status of bioresources Define the status of BBs Promote public consultation Establish the informed consent form Define the access to bioresources Regulate patentability Set up and monitor good practices in biobanking Provide in-formation and permanent training Biobanking 2.0 Marialuisa Lavitrano

Access to Samples and Data

Outreach Public engagement Interdisciplinarity Public Private - Partnerships / Innovation Global integration

BBMRI and Publics Public perception (focus groups and Eurobarometer) Active participation of patient organizations Socio-economic impact study (impact on science, economy, health care) Political engagement process

Expert Centres: Win-Win for Public and Private Sectors Common good (donations) Expertise Expertise Funds Industry Medical data Biological samples Knowledge Primary data generation Diagnostics Drugs Public (not-for-profit) Data Public Private pre-competitive (not-for-profit) Products IPR Standardisation of data generation Basis for data sharing Better usage of finite resources Private (for-profit) Collaborative research to improve innovation